Cancer prevention registry collecting health and genetic information
Texas Regional Excellence in Cancer (TREC) @Texas A&M University Cancer Prevention Registry and Repository
This study is collecting health and genetic information from people to see how different factors affect cancer risk and to find better ways to prevent and treat cancer.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Texas A&M University Academic / other |
| Locations | 1 site (Bryan, Texas) |
| Trial ID | NCT06826014 on ClinicalTrials.gov |
What this trial studies
This observational research collects health and genetic data to explore how factors like genetics, diet, exercise, and occupation influence cancer risk. The study aims to identify strategies for early cancer prevention and treatment by analyzing the collected information. Participants will be followed for five years, and their health records will be shared in a deidentified format for further research. The ultimate goal is to enhance methods for preventing cancers that are difficult to treat.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older who are participating in coordinated cancer screening programs and can provide consent for genetic material donation.
Not a fit: Patients who decline to participate or have a diagnosis of Alzheimer's disease may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved cancer prevention strategies tailored to individual risk factors.
How similar studies have performed: Other studies have shown success in using genetic and lifestyle data to inform cancer prevention strategies, making this approach promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years of age and older, and, * People participating in the Cancer Prevention and Research Institute of Texas (CPRIT) A coordinated cancer screening research program in Bryan and Navasota Family Medicine Clinics and, * People with COPD, liver disease, cervical intraepithelial neoplasia (CIN) lesions, having had a colonoscopy or a low dose computed tomography (LDCT) lung scan or cervical exam in the last 12 months or scheduled for one, and, * Able to give and comprehend the consent process, and, * Able to consent to donate blood and urine samples, genetic material through buccal swabs for future research, and, * Able to understand that their specimens, health record, and changes in health status will be followed for a five-year period and shared in deidentified form with the research community, and, * All sexes and gender identities. Exclusion Criteria: * Declines to participate or interact with staff/share their medical status. * A diagnosis of Alzheimer's disease or related dementias in a medical record indicates a progressive, debilitating condition that impairs memory, thought processes, and functioning Individuals who are unable or unwilling to provide consent will be excluded
Where this trial is running
Bryan, Texas
- Texas A&M Family Care — Bryan, Texas, United States (Recruiting)
Study contacts
- Study coordinator: Kenneth S Ramos, MD
- Email: kramos@tamu.edu
- Phone: 7136777740
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.